"Histiocytosis, Sinus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Benign, non-Langerhans-cell, histiocytic proliferative disorder that primarily affects the lymph nodes. It is often referred to as sinus histiocytosis with massive lymphadenopathy.
| Descriptor ID |
D015618
|
| MeSH Number(s) |
C15.604.250.410.450
|
| Concept/Terms |
Histiocytosis, Sinus- Histiocytosis, Sinus
- Histiocytoses, Sinus
- Sinus Histiocytoses
- Sinus Histiocytosis
- Rosai-Dorfman Disease
- Disease, Rosai-Dorfman
- Rosai Dorfman Disease
- Sinus Histiocytosis with Massive Lymphadenopathy
- Destombes-Rosai-Dorfman Syndrome
- Destombes Rosai Dorfman Syndrome
- Syndrome, Destombes-Rosai-Dorfman
|
Below are MeSH descriptors whose meaning is more general than "Histiocytosis, Sinus".
Below are MeSH descriptors whose meaning is more specific than "Histiocytosis, Sinus".
This graph shows the total number of publications written about "Histiocytosis, Sinus" by people in this website by year, and whether "Histiocytosis, Sinus" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2002 | 0 | 1 | 1 |
| 2004 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 3 | 0 | 3 |
| 2008 | 3 | 0 | 3 |
| 2010 | 2 | 1 | 3 |
| 2011 | 3 | 0 | 3 |
| 2013 | 1 | 0 | 1 |
| 2014 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2017 | 2 | 0 | 2 |
| 2018 | 4 | 0 | 4 |
| 2019 | 3 | 0 | 3 |
| 2020 | 2 | 0 | 2 |
| 2021 | 4 | 0 | 4 |
| 2022 | 3 | 0 | 3 |
| 2023 | 1 | 0 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Histiocytosis, Sinus" by people in Profiles.
-
Mixed histiocytic disorders: Nature versus nurture? Br J Haematol. 2024 Jul; 205(1):20-21.
-
Successful treatment of non-Langerhans cell histiocytosis with the MEK inhibitor trametinib: a multicenter analysis. Blood Adv. 2023 08 08; 7(15):3984-3992.
-
Histiocytic Disorders of Childhood. Pediatr Rev. 2022 Oct 01; 43(10):561-571.
-
Primary Rosai-Dorfman disease of the thymus and lung: A clinicopathological and immunohistochemical study of three cases. Pathol Res Pract. 2022 Jun; 234:153917.
-
Cyclin D1 expression in Rosai-Dorfman disease: a near-constant finding that is not invariably associated with mitogen-activated protein kinase/extracellular signal-regulated kinase pathway activation. Hum Pathol. 2022 03; 121:36-45.
-
Histiocytic Neoplasms, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021 11; 19(11):1277-1303.
-
Histiocytic disorders. Nat Rev Dis Primers. 2021 10 07; 7(1):73.
-
Presentation of External Ear Rosai-Dorfman Disease With Laryngeal Involvement. Ear Nose Throat J. 2023 Jul; 102(7):NP303-NP307.
-
Histiocytic Diseases of Neonates: Langerhans Cell Histiocytosis, Rosai-Dorfman Disease, and Juvenile Xanthogranuloma. Clin Perinatol. 2021 03; 48(1):167-179.
-
Treating Rosai-Dorfman disease and RAS-associated autoimmune leucoproliferative disorder with malignant transformation. Br J Haematol. 2021 02; 192(3):667-671.